Nanjing, China

Wanchen Cui

This inventor holds 1 USPTO granted patent. Top assignee: Nanjing University of Chinese Medicine. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wanchen Cui. Retrieved from https://idiyas.com/inventor/wanchen-cui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wanchen Cui and a Patent for Reducing Oxaliplatin-Related Gastrointestinal Effects.

Introduction

Wanchen Cui is an inventor associated with Nanjing University of Chinese Medicine in Nanjing, China. His patent work includes a formulation intended to help address gastrointestinal adverse effects caused by oxaliplatin.

Latest Patents

Cui is associated with 1 patent: “Combined Formulation Capable of Ameliorating Gastrointestinal Adverse Effects Caused by Oxaliplatin and Preparation Method Therefor and Use Thereof.” The invention describes a combined formulation containing polysaccharides. The disclosed preparation process removes small-molecule substances through ethanol extraction, followed by water reflux extraction and separation using a hollow-fiber ultrafiltration device. The patent states that the formulation may help ameliorate intestinal injury, reduce inflammatory factors, and maintain intestinal barriers. It proposes potential use as a functional food or medicine to mitigate gastrointestinal adverse effects caused by oxaliplatin.

Career Highlights

Cui’s listed patent reflects research into a formulation and preparation method with potential applications in managing treatment-related gastrointestinal effects. The supplied information identifies Nanjing University of Chinese Medicine as his affiliated institution.

Collaborations

The supplied information names Jinao Duan and Sheng Guo as Cui’s coworkers.

Conclusion

Wanchen Cui’s patent focuses on a polysaccharide-containing formulation intended to support intestinal health and reduce gastrointestinal adverse effects associated with oxaliplatin.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…